Ibn Alhaytham Hospital (AMM:IBNH) Growth Rank: 3 (As of Jul. 26, 2026) — 67% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMM:IBNH Ibn Alhaytham Hospital AMM:IBNH
33 GF Score
Price JOD0.86
GF Value JOD0.84
! 9 Warning Signs
View Full Analysis

What is Ibn Alhaytham Hospital Growth Rank?

Ibn Alhaytham Hospital AMM:IBNH 33 Growth Rank is 3 as of Jul. 26, 2026, which is 67% below its 10-year median of 9.00. GuruFocus rates AMM:IBNH with a GF Score™ of 33/100 and a GF Value™ of JOD0.84. The stock has 9 warning signs investors should review.

Ibn Alhaytham Hospital has the Growth Rank of 3.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Ibn Alhaytham Hospital Growth Rank Related Terms

AMM:IBNH vs HCA, THC, DVA: Growth Rank Comparison

For the Medical Care Facilities subindustry, Ibn Alhaytham Hospital's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ibn Alhaytham Hospital Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ibn Alhaytham Hospital's Growth Rank distribution charts can be found below:

* The bar in red indicates where Ibn Alhaytham Hospital's Growth Rank falls into.


AMM:IBNH
33GF Score
Ibn Alhaytham Hospital AMM:IBNH
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 3 mean?
Ibn Alhaytham Hospital (AMM:IBNH) has a Growth Rank of 3 as of Jul. 26, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Ibn Alhaytham Hospital and its competitors. This is 67% below median its historical median of 9.00. Over the past decade, Ibn Alhaytham Hospital's Growth Rank has ranged from 3.00 to 10.00.
Is Ibn Alhaytham Hospital's Growth Rank too high?
Ibn Alhaytham Hospital's current Growth Rank of 3 is 67% below median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 10.00. Overall, Ibn Alhaytham Hospital has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Ibn Alhaytham Hospital's Growth Rank compare to HCA and THC?
Ibn Alhaytham Hospital's Growth Rank of 3 can be compared against companies in the Healthcare Providers & Services industry. Historically, Ibn Alhaytham Hospital's own Growth Rank has ranged from 3.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Ibn Alhaytham Hospital and its competitors. Ibn Alhaytham Hospital's current Growth Rank is 3, which is 67% below median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibn Alhaytham Hospital stock overvalued right now?
Ibn Alhaytham Hospital (AMM:IBNH) has a current Growth Rank of 3. The stock's GF Value™ is JOD0.84, compared to a current price of JOD0.86 — trading 2.4% above its estimated fair value. The current Growth Rank is 3, which is 67% below median its 10-year median of 9.00. Ibn Alhaytham Hospital's overall GF Score™ is 33/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Ibn Alhaytham Hospital (AMM:IBNH), the current Growth Rank is 3 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ibn Alhaytham Hospital (AMM:IBNH) Overvalued in 2026?

Based on GuruFocus' analysis, Ibn Alhaytham Hospital stock appears to be overvalued. The current stock price of JOD0.86 is trading 2.4% above its estimated GF Value™ of JOD0.84.

Key valuation signals for AMM:IBNH:

  • Growth Rank: 3 (67% below median its 10-year median of 9.00)
  • GF Value™: JOD0.84 vs. price of JOD0.86 (2.4% above fair value)
  • GF Score™: 33/100 with 9 warning signs

No single metric tells the full story. See the AMM:IBNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ibn Alhaytham Hospital Business Description

Address Al-Madina Al-Monawara Street, Amman, JOR, 11194
Ibn Alhaytham Hospital operates as a hospital in Jordan. The Company's main objectives is to found and establish a hospital for general casses And especially ophthalmology, Otorhinolaryngology, Medicine and Neurosurgery and to Import a necessary medical equipment and supplies. The company operates in segments, which comprise of Medical & investments and others.
33GF Score

Get the complete analysis for AMM:IBNH

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD0.86
Price
JOD0.84
GF Value